Inventor profile of:

Eric J. Benjamin

City:

Jamestown, North Carolina

Country:

United States

Published Applications:

14

Last publication date:

2018-07-12

Top Assignees for applications by Eric J. Benjamin

The entities that hold a legal rights for patent applications filed by inventor Benjamin Eric J.:

Recent patent applications by Benjamin Eric J.

Eric J. Benjamin from Jamestown, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2018-07-12
US20180193311A1
Human necessities

Sustained release pharmaceutical compositions

#2 | 2011-11-17
US20110282035A1
Chemistry; metallurgy

Nucleic acid molecules encoding rage fusion proteins

#3 | 2010-03-11
US20100062058A1
Human necessities

Delayed Release Formulations for Oral Administration of a Polypeptide Therapeutic Agent and Methods of Using Same

#4 | 2008-07-03
US20080161336A1
Human necessities

Orally bioavailable CCI-779 formulations

#5 | 2008-03-20
US20080070950A1
Chemistry; metallurgy

Amorphous rapamycin 42-ester with 3-hydroxy-2-(hydroxymethyl)-2-methylpropionic acid and its pharmaceutical compositions

#6 | 2008-02-21
US20080045455A1
Chemistry; metallurgy

RAGE fusion proteins, formulations, and methods of use thereof

#7 | 2007-08-09
US20070185204A1
Human necessities

Crystalline forms of 3-biphenyl-4-yl-(2S)-[(4'-trifluoromethyl-biphenyl-4-carbonyl)-amino]-propionic acid, and methods of use

#8 | 2007-04-12
US20070082952A1
Human necessities

Pharmaceutical compositions, methods of preparation thereof, and methods of treatment

#9 | 2006-08-17
US20060183766A1
Human necessities

Orally bioavailable CCI-779 formulations

#10 | 2005-07-14
US20050152983A1
Human necessities

Directly compressible pharmaceutical composition for the oral administration of CCI-779

#11 | 2005-06-30
US20050142192A1
Human necessities

Oral administration of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl] phosphonic acid and derivatives

#12 | 2005-05-05
US20050095292A1
Human necessities

Sustained release pharmaceutical compositions

#13 | 2005-03-03
US20050049271A1
Chemistry; metallurgy

Amorphous rapamycin 42-ester with 3-hydroxy-2-(hydroxymethyl)-2-methylpropionic acid and its pharmaceutical compositions

#14 | 2005-01-06
US20050004079A1
Human necessities

Pharmaceutical compositions for intranasal administration of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl] phosphonic acid and derivatives and methods of use thereof

InventorID:

2238794 ⎘